Optimizing Antidepressant Treatment by Genotype-dependent Adjustment of Medication According to the ABCB1 Gene

NCT02237937 · clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
80
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

HolsboerMaschmeyer NeuroChemie GmbH

Collaborators